BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 31663769)

  • 1. Impact of menopausal hormone formulations on pituitary-ovarian regulatory feedback.
    Kling JM; Dowling NM; Bimonte-Nelson HA; Gleason CE; Kantarci K; Manson JE; Taylor HS; Brinton EA; Lobo RA; Cedars MI; Pal L; Neal-Perry G; Naftolin F; Harman SM; Miller VM
    Am J Physiol Regul Integr Comp Physiol; 2019 Dec; 317(6):R912-R920. PubMed ID: 31663769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
    Reyes FI; Winter JS; Faiman C
    Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Oral vs Transdermal Estrogen Therapy on Sexual Function in Early Postmenopause: Ancillary Study of the Kronos Early Estrogen Prevention Study (KEEPS).
    Taylor HS; Tal A; Pal L; Li F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Du W; Hodis HN; Lobo RA; Manson JE; Merriam GR; Miller VM; Naftolin F; Neal-Perry G; Santoro NF; Harman SM
    JAMA Intern Med; 2017 Oct; 177(10):1471-1479. PubMed ID: 28846767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between pituitary-ovarian hormones and cognition in recently menopausal women independent of type of hormone therapy.
    Kling JM; Dowling NM; Bimonte-Nelson H; Gleason CE; Kantarci K; Stonnington CM; Harman SM; Naftolin F; Pal L; Cedars M; Manson JE; James TT; Brinton EA; Miller VM
    Maturitas; 2023 Jan; 167():113-122. PubMed ID: 36395695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal estrogen replacement therapy in normal perimenopausal women: effects on pituitary-ovarian function.
    De Leo V; Lanzetta D; D'Antona D; De Palma P
    Gynecol Endocrinol; 1996 Feb; 10(1):49-53. PubMed ID: 8737192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of oral versus transdermal menopausal hormone treatments on self-reported sleep domains and their association with vasomotor symptoms in recently menopausal women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS).
    Cintron D; Lahr BD; Bailey KR; Santoro N; Lloyd R; Manson JE; Neal-Perry G; Pal L; Taylor HS; Wharton W; Naftolin F; Harman SM; Miller VM
    Menopause; 2018 Feb; 25(2):145-153. PubMed ID: 28832429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of pituitary-ovarian hormones and white matter hyperintensities in recently menopausal women using hormone therapy.
    Kling JM; Miller VM; Tosakulwong N; Lesnick T; Kantarci K
    Menopause; 2020 Aug; 27(8):872-878. PubMed ID: 32520900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of aging and gonadal failure on the hypothalamic-pituitary axis in women.
    Santoro N; Banwell T; Tortoriello D; Lieman H; Adel T; Skurnick J
    Am J Obstet Gynecol; 1998 Apr; 178(4):732-41. PubMed ID: 9579435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart fat and carotid artery atherosclerosis progression in recently menopausal women: impact of menopausal hormone therapy: The KEEPS trial.
    El Khoudary SR; Venugopal V; Manson JE; Brooks MM; Santoro N; Black DM; Harman M; Naftolin F; Hodis HN; Brinton EA; Miller VM; Taylor HS; Budoff MJ
    Menopause; 2020 Mar; 27(3):255-262. PubMed ID: 32015261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of the steroid sex hormones on the LH and FSH responses to LHRH in the normal subject].
    Lemarchand-Béraud T; Reymond M; Rappoport G; Magrini G; Gomez J
    Pathol Biol (Paris); 1975 Dec; 23(10):917-22. PubMed ID: 772543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of sex steroids on pituitary responsiveness to gonadotropin releasing hormone.
    Eshkol A; Lunenfeld B; Insler V
    J Steroid Biochem; 1975 Jun; 6(6):1061-6. PubMed ID: 1100906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study.
    Santoro N; Allshouse A; Neal-Perry G; Pal L; Lobo RA; Naftolin F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Dowling NM; Dunn M; Gleason CE; Hodis HN; Isaac B; Magnani M; Manson JE; Miller VM; Taylor HS; Wharton W; Wolff E; Zepeda V; Harman SM
    Menopause; 2017 Mar; 24(3):238-246. PubMed ID: 27779568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of ovulation by progestin analogs (agonists vs antagonists): preliminary evidence for different sites and mechanisms of actions.
    Heikinheimo O; Gordon K; Williams RF; Hodgen GD
    Contraception; 1996 Jan; 53(1):55-64. PubMed ID: 8631191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Postmenopausal Transdermal 17β-Estradiol Therapy and Amyloid-β Deposition.
    Kantarci K; Lowe VJ; Lesnick TG; Tosakulwong N; Bailey KR; Fields JA; Shuster LT; Zuk SM; Senjem ML; Mielke MM; Gleason C; Jack CR; Rocca WA; Miller VM
    J Alzheimers Dis; 2016 May; 53(2):547-56. PubMed ID: 27163830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary and ovarian function in women receiving hormonal contraception.
    Cohen BL; Katz M
    Contraception; 1979 Nov; 20(5):475-87. PubMed ID: 393456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative randomized trial on the impact of two low-dose oral contraceptives on ovarian activity, cervical permeability, and endometrial receptivity.
    Rossmanith WG; Steffens D; Schramm G
    Contraception; 1997 Jul; 56(1):23-30. PubMed ID: 9306028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
    Carlström K; Lunell NO; Zador G
    Gynecol Obstet Invest; 1978; 9(6):304-11. PubMed ID: 754992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in hypophysio-ovarian endocrinological function of post-menopausal and castrated women.
    Furuhashi N; Abe T; Suzuki M; Yamaya Y; Takahashi K
    Tohoku J Exp Med; 1976 Sep; 120(1):19-24. PubMed ID: 960105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
    de Ziegler D; Steingold K; Cedars M; Lu JK; Meldrum DR; Judd HL; Chang RJ
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further studies on pituitary and ovarian function in women receiving hormonal contraception.
    Cohen BL; Katz M
    Contraception; 1981 Aug; 24(2):159-72. PubMed ID: 6794980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.